BIO Association, a Swiss non-profit founded by key members of VitaDAO, the DeSci decentralized science organization backed by Pfizer Ventures and Balaji Srinivasan, today officially announced its community launch and fair launch. BIO Association aims to develop a decentralized biotech network and serve as a launchpad for on-chain scientific communities, connecting the biotech and cryptocurrency fields. Currently, the BIO network consists of eight different scientific communities focusing on areas such as longevity, women's health, neurodegenerative diseases, and synthetic biology.
This launch of BIO gives the public the opportunity to exchange ETH or other DeSci tokens for $BIO tokens before the BIO protocol goes live.
Democratizing access to scientific research and funding
BIO has the potential to revolutionize the biotech industry by democratizing access to scientific research and funding. Using DeSci and blockchain technology, we can create BioDAOs, community-owned organizations that collaborate to develop and fund scientific intellectual property on a global scale. This approach breaks down traditional barriers in the biotech sector, accelerates innovation, and allows for more transparent and fair participation by researchers, patients, and enthusiasts from around the world.
Fair Launch and Community Genesis Plan
In the spirit of early cryptocurrency launches such as Ethereum, Solana, and Arweave, the BIO Association has chosen a fair and open launch approach. This approach reflects the community’s commitment to transparency and equal opportunity in the rapidly evolving DeSci field.
BIO tokens give holders the power to screen new BioDAOs incubated by the future BIO Network, as well as whitelist access to new scientific research projects funded by top universities and researchers, allowing anyone to become an early beneficiary of the development of new drugs and products in the BIO Network.
As attention to DeSci continues to grow, innovations in the BIO ecosystem are attracting funding at an increasingly rapid rate. Success stories include VitaRNA, a new gene therapy for aging, which recently saw its value rise by 150% in one day after positive results from in vitro testing. At the same time, DeSci DAO tokens in the BIO ecosystem are also rising, such as HairDAO's HAIR token, which has increased more than 10 times since its launch in 2023.
Genesis Token Holders List
The BIO Association is backed by a diverse group of investors from the biotech, cryptocurrency, and venture capital sectors. Spinning off from Molecule AG, a Swiss company building the tokenized infrastructure for DeSci organizations, BIO genesis token holders include: ZeePrime Capital, Beaker DAO, Boost VC, 1kx, ID Theory, Compound, Cherry Crypto, L1D, Fifty Years, Northpond Ventures, KdT Ventures, Sora Ventures, and The LAO.
Innovative startup mechanism
The BIO Association launched an innovative fair launch mechanism, with the first auction held in August during the bear market and successfully raising over $5 million. The mainnet launch is planned to be on Ethereum, in line with other well-known DeSci projects.
Looking ahead
In the coming weeks, the BIO Association will announce selected strategic participants, further solidifying its position in the industry. These upcoming announcements will highlight the project’s strong ties to the biotech and crypto sectors.
During BIO's community genesis event, users can exchange BIO tokens for ETH or DeSci DAO tokens in the BIO network. The genesis event will last for 45 days or end early when the funding amount brings the fully diluted valuation (FDV) of BIO tokens to the $100 million cap. After the event, BIO tokens will be temporarily non-transferable until the circulation rights are unlocked through community governance voting.
About BIO
The BIO Association is a non-profit organization focused on developing the BIO Protocol, an innovative protocol designed to guide capital and talent into the field of decentralized science (DeSci). The BIO Protocol provides decentralized funding, liquidity, and incentives for the on-chain scientific community (i.e., "BioDAO") to advance preclinical research by combining DeFi technology with real-world IP intellectual property. Revenue from IP sales, licensing, and health products will circulate back to the network to provide continued financial support for the next generation of biomedical research and development. This decentralized model enables researchers, supporters, and community enthusiasts around the world to work closely together on scientific innovation and more efficiently turn biotechnology results into reality. BIO was founded by core members of VitaDAO, a decentralized science organization backed by Pfizer Ventures and Balaji Srinivasan.
For more information, visit bio.xyz or contact: Nate Hindman (nate@bio.xyz)
